Federal Health Panel’s Move to Delay Hepatitis B Vaccine Puts American Babies at Risk

How did a proven lifesaving vaccine become a target in Washington’s latest health gamble? The hepatitis B shot, recommended for newborns for over 30 years and credited with dramatically reducing liver cancer and chronic infection rates, now faces unprecedented scrutiny. Under the direction of Health Secretary Robert F. Kennedy Jr., a federal advisory committee is poised to reconsider the birth dose recommendation, potentially reversing public health gains and endangering vulnerable American children. Is Washington Undermining Proven Public Health Successs for Political or Ideological Reasons? The hepatitis B virus remains a serious threat: it silently infects millions across the U.S., with...